Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases

The Lancet

Volumn 344, Issue 8932, 1994, Pages 1255-1260

  Allen Mersh, T G ^a   Earlam, S ^a   Fordy, C ^a   Abrams, K ^b   Houghton, J ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CARCINOEMBRYONIC ANTIGEN; FLOXURIDINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG EFFICACY; HEPATIC ARTERY; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL TIME; TUMOR VOLUME;

EID: 0028150629     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)90750-1     Document Type: Article

References (30)

1. Hepatic metastases from colorectal cancer: resection or not?
2. Resection of hepatic metastases from colorectal cancer
3. Regional infusion chemotherapy-where is it going?
4. Advanced colorectal cancer meta analysis project Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer evidence in terms of response rate
5. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion
6. Recent advances in the treatment of advanced colorectal cancer
7. Clinical perspective of human colorectal cancer metastasis
8. Pain in malignant disease
9. A randomised trial of intrahepatic infusion of FUDR with dexamethasone versus FUDR alone in the treatment of metastatic colorectal cancer
10. Assessing quality of life in cancer patients
11. Quality of life adjusted survival, TWIST, QTWIST
12. The effect of radical and conserving surgery on the quality of life of early breast cancer patients
13. The hospital anxiety and depression scale
14. Factors influencing survival in patients with untreated hepatic metastases
15. Design and analysis of randomised clinical trials requiring prolonged observations of each patient: II analysis and examples
16. Statistical analysis of longitudinal quality of life data with missing values
17. Minimisation
18. Can the subsequent development of colorectal liver metastases be predicted?
19. Prognostic factors in advanced colorectal carcinoma: the importance of lactic dehydrogenase, performance status and white blood cell count
20. Prognostic factors in colorectal cancer
21. Overview of clinical trials using 5FU and leucovorin for the treatment of colorectal cancer
22. A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer
23. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomised trial
24. Cancer chemotherapy and quality of life
25. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: longterm results of a prospective randomised trial
26. Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer
27. A prospective randomised trial comparing the infectious and non-infectious complications of an externalised catheter versus a subcutaneously implanted device in cancer patients
28. Update of randomised study of intrahepatic vs systemic infusion of FUDR in patients with liver metastases from colorectal carcinoma
29. A prospective randomised trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases
30. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer